Li‐An K. Brown

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Guy Thwaites, Matthew Scarborough, Alexander J. Szubert et al. · The Lancet · 2017 · 187 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Treatment of chronic or relapsing COVID-19 in immunodeficiency

Li‐An K. Brown, Ed Moran, Anna L. Goodman et al. · Journal of Allergy and Clinical Immunology · 2021 · 92 citations · Full text

Life Sciences, Immunology, Infectious Diseases +10

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

David M. Lowe, Li‐An K. Brown, Kashfia Chowdhury et al. · PLoS Medicine · 2022 · 34 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Clinical Features, Immunological Characteristics, and Treatment Outcomes of Campylobacter spp. Infections in Patients With Common Variable Immunodeficiency

Adriel Roa‐Bautista, Li‐An K. Brown, Susan Tadros et al. · The Journal of Allergy and Clinical Immunology In Practice · 2023 · 19 citations · Full text

Life Sciences, Immunology, Microbiology +14

Use of Cefiderocol in the Management of Children With Infection or Colonization With Multi-drug Resistant Gram-negative Bacteria: A Retrospective, Single-center Case Series

Hanna Schmid, Li‐An K. Brown, Bairavi Indrakumar et al. · The Pediatric Infectious Disease Journal · 2024 · 11 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17